טוען...
Anti-IL5 therapy for asthma and beyond
Airway inflammation is considered to be the primary component contributing to the heterogeneity and severity of airway disorders. Therapeutic efficacies of diverse novel biologics targeting the inflammatory pathways are under investigation. One such target is IL-5, a type-1 cytokine that is central...
שמור ב:
| הוצא לאור ב: | World Allergy Organ J |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4326373/ https://ncbi.nlm.nih.gov/pubmed/25709744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1939-4551-7-32 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|